Recently enacted health care reform legislation presents life sciences companies with many business challenges and opportunities. This program will provide a roadmap to navigate through the new legal requirements and issues that will affect companies, as well as provide information and guidance about how to access federal funds and influence the regulatory implementation process.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.